简化生物仿真基载体,用于增强瘤透和快速酶诱导的药物释放
Weili Xue1, Xinyue Wei2, Ziyin Xiang2
1State Key Laboratory of Metastable Materials Science and Technology, Nano-biotechnology Key Lab of Hebei Province, Applying Chemistry Key Lab of Hebei Province, Heavy Metal Deep-Remediation in Water and Resource Reuse Key Lab of Hebei, Yanshan University, Qinhuangdao 066004, China.
Journal of colloid and interface science
|January 9, 2025
概括
这项研究引入了一种简化的阿尔伯明仿真载体,用于增强多克索鲁比 (Dox) 输送. 这种新型纳米药物平台改善了瘤向和受控释放,为潜在的临床用途.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 目前的纳米药物在瘤传递效率和非目标释放方面面临挑战.
- 专蛋白固有的瘤向能力激发了新的药物输送策略.
研究的目的:
- 开发一种简化,模仿白蛋白的基纳米车,用于增强瘤治疗.
- 为了将多克索鲁比辛 (Dox) 封装在这个新架中.
主要方法:
- 通过与L-phenylalanine (F) 共聚合L-glutamyl-L-lysine (EK二聚体) 来合成一个载体.
- 利用zwitterionic外来模仿白蛋白的表面特性.
- 对受控药物释放的酶触发降解 (甲素B) 进行了研究.
主要成果:
- 这种载体通过模仿白来证明了长时间的血液循环.
- 通过改变瘤细胞外矩阵粘度来实现增强的瘤透.
- 瘤特异性酶 (cathepsin B) 触发了多克索鲁比辛的快速释放.
结论:
- 简化蛋白模仿载体为改善纳米药物输送提供了一个有前途的平台.
- 这种方法解决了当前纳米药物临床转化方面的关键局限性.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
308
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308
Modified-Release Drug Delivery Systems: Stimuli-Activated
124
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
124
Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
Site-Targeted Drug Delivery Systems: Polymeric Carriers
115
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
115


